Epistem Announces Opening of US Laboratory
News Mar 06, 2014
Epistem Holdings Plc has announced that it has opened a US laboratory based in Baltimore, Maryland. The laboratory will support the expansion of Epistem's contract research division within the US.
The US laboratory is currently offering histology and immunohistochemistry (IHC) services to a range of US clients, expanding upon the success of the GcLP and GLP compliant UK laboratory.
The experienced and skilled technical team have already developed IHC protocols for a panel of over 150 antibodies which are available to clients worldwide.
Epistem Co-Founder and Director of the Contract Services Business, Dr Catherine Booth commented "Epistem's specialist contract research services provide valuable support to drug discovery and development pipelines. We already have strong relationships with both companies, academic and government groups on the East Coast along with a US Business team based in Boston and Baltimore. We are excited to now be providing services locally to support this growing US business".
Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019